The perimenopause market is expected to reach $25bn by 2030, driven by pharmaceutical companies addressing women's health needs. However, the consumer side of this market is experiencing rapid growth, with brands offering a wide array of menopause-friendly products.
Concerns have been raised about a 'menopause gold rush', where women may be exploited through products with limited scientific backing. Professor Joyce Harper of UCL co-authored a paper reviewing over 200 menopause supplements, noting significant variations in ingredients and price, and a lack of consensus on their effectiveness. Only vitamin D and calcium are recommended by medical experts for bone health, with sufficient proof of efficacy.
The consumer magazine Which? has also highlighted a 'pink tax', where manufacturers may sell standard products like moisturiser and vitamins at a higher price simply by rebranding them for menopause. This trend has led to questions about 'menowashing', where brands use women's health needs to sell potentially unnecessary items during a vulnerable time.
An event in London, Pause Live, showcased a range of products from menthol lotions to herbal supplements and 'pant magnets' for hot flushes. While some attendees viewed it as a social outing, others expressed disappointment over the lack of focus on mental health and concerns about 'menowashing'.